High Price Tag for New, Long-Awaited Gene Therapies
Dec. 30, 2021 – By 2025, 10 to 20 new cell and gene therapies will likely be approved each year, according to the FDA. Great news, right? These products could save countless lives of people living with rare genetic diseases, like Sickle Cell, Progeria, and Spina Bifida. The hefty price tag for these treatments, however, … Read more